Načítá se...
Immunosignature Screening for Multiple Cancer Subtypes Based on Expression Rule
Liquid biopsy (i.e., fluid biopsy) involves a series of clinical examination approaches. Monitoring of cancer immunological status by the “immunosignature” of patients presents a novel method for tumor-associated liquid biopsy. The major work content and the core technological difficulties for the m...
Uloženo v:
| Vydáno v: | Front Bioeng Biotechnol |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Frontiers Media S.A.
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6901955/ https://ncbi.nlm.nih.gov/pubmed/31850330 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fbioe.2019.00370 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|